My SNMMI Overview
MEMBER DIRECTORY
LEARNING CENTER
SNMMI AI Task Force Activities Abhinav Jha, PhD
The Role of AI in Drug and Biomarker Development Amir Iravani, MD, FRACP
Workflow Basics for Imaging and Dosimetry in RPT with a Focus on the Role of AI Julia Brosch-Lenz, PhD
Predicting Absorbed Doses and Response with AI Yuni K Dewaraja, PhD, FSNMMI
AI-Enhanced Clinical Translation of Alpha Dosimetry Kuangyu Shi, PhD
An Introduction to Large Language Models and Large Multimodal Models Tyler Bradshaw, PhD
Arena Session Panelist Eliot L. Siegel, MD Pedram Heidari, MD Mario Jreige, MD
Organizer(s): AI Task Force/Guido Davidzon, Jazmin Schwartz, Dmitry Beyder Moderator(s): Guido Davidzon, Jazmin Schwartz, Dmitry Beyder
Opening Remarks Abhinav Jha, PhD
Subtle PET Enhao Gong
Nuclarity Tomas Brants
Diffusion Transformer PET Denoising Ziyuan Zhou
Q&A Block 1
AI Parametric MBF Maps with Rb82 Eric Moulton
Pre-Therapy PET Tzu-An Song
VAE-Based AD Sub-Typing and Staging Fan Yang
WB FDG PET/CT Disease Burden Quantification Vijay Shah
Q&A Block 2
NucAI Sienna Berte
TheraSeg Uttkarsh Chaurasia
Agentic AI Education Tools Justin Peacock
Q&A Block 3
Closing Comments Tyler Bradshaw
Q&A
NucLex: Towards Standardized Terminology and Data Models in Theranostics and Radiopharmaceutical Therapies (Nuclear Medicine Ontology) Babak Saboury, MD, MPH, DABR, DABNM
Clinical Decision Making Guided by Computational Nuclear Oncology Solutions Pedram Heidari, MD